Dietary Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Comparing Mediterranean, Low-Carbohydrate, Ketogenic, and Time-Restricted Eating Approaches
Year: 2026
Type: article
Abstract: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent metabolic liver disorder closely associated with obesity, insulin resistance, dyslipidemia, and other cardiometabolic risk factors. Lifestyle modification, particularly dietary intervention, remains a cornerstone of MASLD management; however, the optimal dietary strategy for improving hepatic steatosis and metabolic health remains incompletely established. This review examines and compares the evidence supporting four dietary approaches Mediterranean, lowcarbohydrate, ketogenic, and time-restricted eating in the management of MASLD. Particular attention is given to their effects on hepatic fat accumulation, body weight, insulin sensitivity, glycemic control, lipid metabolism, and other relevant metabolic and liver-related outcomes. The Mediterranean diet is characterized by a high intake of vegetables, fruits, whole grains, legumes, nuts, and olive oil, and has demonstrated consistent benefits for overall metabolic health and cardiovascular risk, with emerging evidence supporting improvements in hepatic steatosis. Low-carbohydrate and ketogenic diets may promote substantial weight loss and improve glycemic and insulin-related parameters, potentially contributing to reductions in liver fat; however, their long-term efficacy, sustainability, and nutritional adequacy require further consideration. Time-restricted eating represents a potentially practical approach that modifies the timing of food intake rather than prescribing specific macronutrient compositions and may improve metabolic outcomes through weight loss and enhanced circadian metabolic regulation. Across these dietary strategies, improvements in MASLD appear to be influenced substantially by energy restriction, weight reduction, dietary quality, adherence, and individual metabolic characteristics. Current evidence therefore does not support a universally superior dietary pattern for all patients with MASLD. Instead, dietary management should be individualized according to metabolic status, nutritional preferences, comorbidities, lifestyle factors, and the likelihood of long-term adherence. Further well-designed, adequately powered, long-term randomized controlled trials are needed to directly compare these approaches and clarify their independent effects on liver-specific outcomes. Overall, integrating dietary quality, sustainable weight management, and individualized eating patterns may provide the most effective framework for nutritional management of MASLD.
Author: Manal Almatrafi
Institution: Taif University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7206164954
